1,960 hedge funds and large institutions have $144B invested in Pfizer in 2016 Q3 according to their latest regulatory filings, with 75 funds opening new positions, 885 increasing their positions, 763 reducing their positions, and 81 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less call options, than puts

Call options by funds: $ | Put options by funds: $

less first-time investments, than exits

New positions opened: | Existing positions closed:

1% less funds holding

Funds holding: 1,9891,960 (-29)

5% less capital invested

Capital invested by funds: $152B → $144B (-$8.2B)

18% less funds holding in top 10

Funds holding in top 10: 286234 (-52)

Holders
1,960
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
234
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.25B
Puts
$2.33B
Net Calls
Net Calls Change

Top Buyers

1 +$351M
2 +$340M
3 +$281M
4
Renaissance Technologies
Renaissance Technologies
New York
+$240M
5
JP Morgan Chase
JP Morgan Chase
New York
+$183M
Name Holding Trade Value Shares
Change
Change in
Stake
1726
$335K
1727
$334K
1728
$332K
1729
$331K
1730
$330K
1731
$330K
1732
$329K
1733
$328K
1734
$327K
1735
$327K
1736
$326K
1737
$326K
1738
$325K
1739
$322K
1740
$321K
1741
$321K
1742
$321K
1743
$320K
1744
$320K
1745
$315K
1746
$315K
1747
$313K
1748
$313K
1749
$312K
1750
$311K